2-[[1-(3,4-dimethoxyphenyl)-9H-pyrido[3,4-b]indole-3-carbonyl]amino]propanoic acid

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: 2-[[1-(3,4-dimethoxyphenyl)-9H-pyrido[3,4-b]indole-3-carbonyl]amino]propanoic acid
• 化学式: C₂₃H₂₁N₃O₅
• 分子量: 419.4
• InChiKey: XLAXHENBAXJTRE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  31
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS
  申请人：Sheridan Joseph M.

  公开号：US20140018540A1

  公开（公告）日：2014-01-16

  The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
• CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
  申请人：Sheridan Joseph M.

  公开号：US20140031547A1

  公开（公告）日：2014-01-30

  The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
• CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES
  申请人：Electrophoretics Limited

  公开号：US20160354375A1

  公开（公告）日：2016-12-08

  The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
• US9763947B2
  申请人：——

  公开号：US9763947B2

  公开（公告）日：2017-09-19
• US9789111B2
  申请人：——

  公开号：US9789111B2

  公开（公告）日：2017-10-17